Austedo XR OK'd; USPSTF's Perinatal Depression Plan; Cannabis Use Disorder Rising

(MedPage Today) -- The FDA approved a once-daily, extended-release version of deutetrabenazine (Austedo XR) in 6, 12, and 24 mg tablet strengths for adults with tardive dyskinesia and chorea associated with Huntington's disease, Teva Pharmaceuticals...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news